BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,069 | +72356.4% | 61,348 | +45343.0% | 0.00% | – |
| Q4 2022 | $243 | -75.7% | 135 | -76.4% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 573 | -45.6% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 1,054 | -46.3% | 0.00% | – |
| Q1 2022 | $5,000 | -86.5% | 1,962 | -71.5% | 0.00% | – |
| Q4 2021 | $37,000 | -91.1% | 6,896 | -85.9% | 0.00% | – |
| Q3 2021 | $414,000 | -39.6% | 48,898 | -13.0% | 0.00% | – |
| Q2 2021 | $685,000 | -77.9% | 56,200 | -56.1% | 0.00% | -100.0% |
| Q1 2021 | $3,103,000 | +1198.3% | 127,891 | +1612.1% | 0.00% | – |
| Q4 2020 | $239,000 | +177.9% | 7,470 | +161.6% | 0.00% | – |
| Q3 2020 | $86,000 | -49.1% | 2,856 | -28.4% | 0.00% | – |
| Q2 2020 | $169,000 | +92.0% | 3,989 | +12.8% | 0.00% | – |
| Q1 2020 | $88,000 | – | 3,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 634,191 | $1,820,128 | 2.14% |
| NEA Management Company, LLC | 4,448,757 | $12,767,933 | 0.99% |
| CHI Advisors LLC | 720,000 | $2,066,400 | 0.82% |
| Bellevue Group AG | 8,135,839 | $23,349,858 | 0.38% |
| Parkman Healthcare Partners LLC | 520,587 | $1,494,085 | 0.27% |
| Artal Group S.A. | 2,046,517 | $5,874 | 0.25% |
| RA Capital Management | 3,525,754 | $10,118,914 | 0.20% |
| Ikarian Capital, LLC | 555,572 | $1,594,492 | 0.19% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,148,000 | 0.16% |
| Newtyn Management, LLC | 205,000 | $588,350 | 0.14% |